×
About 6 results

ALLMedicine™ Aspartylglycosaminuria Center

Research & Reviews  3 results

Aspartylglycosaminuria: a review.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134220
Orphanet Journal of Rare Diseases; Arvio M, Mononen I

Dec 2nd, 2016 - Aspartylglucosaminuria (AGU), a recessively inherited lysosomal storage disease, is the most common disorder of glycoprotein degradation with a high prevalence in the Finnish population. It is a lifelong condition affecting on the patient's appear...

Aspartylglycosaminuria
https://rarediseases.info.nih.gov/diseases/5854/aspartylglycosaminuria

Aug 16th, 2011 - Aspartylglycosaminuria is a very rare lysosomal storage disease that causes a progressive decline in mental functioning. Infants with aspartylglycosaminuria appear healthy at birth with signs and symptoms beginning around the age of 2 or 3. Major ...

Early initiation of enzyme replacement therapy improves metabolic correction in the bra...
https://doi.org/10.1007/s10545-010-9158-7
Journal of Inherited Metabolic Disease; Dunder U, Valtonen P et. al.

Jul 7th, 2010 - Aspartylglycosaminuria (AGU) is a lysosomal storage disease caused by deficient activity of glycosylasparaginase (AGA), and characterized by motor and mental retardation. Enzyme replacement therapy (ERT) in adult AGU mice with AGA removes the accu...

see more →

Clinicaltrials.gov  3 results

Aspartylglycosaminuria: a review.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134220
Orphanet Journal of Rare Diseases; Arvio M, Mononen I

Dec 2nd, 2016 - Aspartylglucosaminuria (AGU), a recessively inherited lysosomal storage disease, is the most common disorder of glycoprotein degradation with a high prevalence in the Finnish population. It is a lifelong condition affecting on the patient's appear...

Aspartylglycosaminuria
https://rarediseases.info.nih.gov/diseases/5854/aspartylglycosaminuria

Aug 16th, 2011 - Aspartylglycosaminuria is a very rare lysosomal storage disease that causes a progressive decline in mental functioning. Infants with aspartylglycosaminuria appear healthy at birth with signs and symptoms beginning around the age of 2 or 3. Major ...

Early initiation of enzyme replacement therapy improves metabolic correction in the bra...
https://doi.org/10.1007/s10545-010-9158-7
Journal of Inherited Metabolic Disease; Dunder U, Valtonen P et. al.

Jul 7th, 2010 - Aspartylglycosaminuria (AGU) is a lysosomal storage disease caused by deficient activity of glycosylasparaginase (AGA), and characterized by motor and mental retardation. Enzyme replacement therapy (ERT) in adult AGU mice with AGA removes the accu...

see more →